Abstract

Helicobacter pylori (H. pylori) is a 0.5–1 µm wide, 2–4 µm long, short helical, S-shaped Gram-negative microorganism. It is mostly found in the pyloric region of the stomach and causes chronic gastric infection. It is estimated that these bacteria infect more than half of the world’s population. The mode of transmission and infection of H. pylori is still not known exactly, but the faecal–oral and oral–oral routes via water or food consumption are thought to be a very common cause. In the last three decades, research interest has increased regarding the pathogenicity, microbial activity, genetic predisposition, and clinical treatments to understand the severity of gastric atrophy and gastric cancer caused by H. pylori. Studies have suggested a relationship between H. pylori infection and malabsorption of essential micronutrients, and noted that H. pylori infection may affect the prevalence of malnutrition in some risk groups. On the other hand, dietary factors may play a considerably important role in H. pylori infection, and it has been reported that an adequate and balanced diet, especially high fruit and vegetable consumption and low processed salty food consumption, has a protective effect against the outcomes of H. pylori infection. The present review provides an overview of all aspects of H. pylori infection, such as clinical features, treatment, and nutrition.

Highlights

  • Helicobacter pylori (H. pylori) was first identified in the stomach of dogs as a spiral microorganism by Giulio Bizzozero in 1892 [1]

  • H. pylori plays a role in the development of diseases such as gastritis and mucosa-associated lymphoid tissue (MALT) lymphoma, as well as peptic ulcer and gastric cancer [8]

  • A study conducted in Nepal reported that 18.2% of 6- to 59-month-old children, 14% of boys and 16% of girls aged 10–19 years, and 40% of non-pregnant women aged 20–49 years were infected with H. pylori [28]

Read more

Summary

Introduction

Helicobacter pylori (H. pylori) was first identified in the stomach of dogs as a spiral microorganism by Giulio Bizzozero in 1892 [1]. As they are Campylobacter-like spiral microorganisms, they were named Campylobacter pyloridis by Barry Marshall and Robin. Marshall and Warren were awarded the Nobel Prize in 2005 for their work on H. pylori in the field of physiology “for discovering the role of H. pylori bacteria in gastritis and peptic ulcer disease” [7]. H. pylori plays a role in the development of diseases such as gastritis and mucosa-associated lymphoid tissue (MALT) lymphoma, as well as peptic ulcer and gastric cancer [8]

Objectives
Methods
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call